Mark David Kollar
Dentist at Ctr Ave, Fort Collins, CO
License number
Colorado 7124
Issued Date
Oct 29, 1993
Renew Date
Mar 1, 2016
Expiration Date
Feb 28, 2018
Type
Dentist
Address
Address
1000 Centre Ave STE 120, Fort Collins, CO 80526
Personal information
See more information about Mark David Kollar at radaris.comName
Address
Phone
916 Akin Ave, Fort Collins, CO 80521
5308 Golden Willow Dr, Fort Collins, CO 80528
Professional information
Founder, Director At St. Renatus
Position:
founder, director at St. Renatus
Location:
Fort Collins, Colorado Area
Industry:
Pharmaceuticals
Work:
St. Renatus
-
founder, director
Skills:
Start-ups, Team Building
Founder, Director At St. Renatus
Position:
founder, director at St. Renatus
Location:
Fort Collins, Colorado Area
Industry:
Pharmaceuticals
Work:
St. Renatus
-
founder, director
Education:
U of MN School of Dentistry 1983
DDS Concordia College, Moorhead, MN 1978
Bachelor of Arts (B.A.), Biology, General
DDS Concordia College, Moorhead, MN 1978
Bachelor of Arts (B.A.), Biology, General
Ceo At Apollonia, Llc
Position:
CEO at apollonia, llc
Location:
Fort Collins, Colorado Area
Industry:
Pharmaceuticals
Work:
apollonia, llc
-
CEO
Dr. Mark D Kollar, Fort Collins CO - DDS (Doctor of Dental Surgery)
Specialties:
Dentistry
Address:
1000 Centre Ave, Fort Collins 80526
(970) 282-0156 (Phone)
(970) 282-0156 (Phone)
Languages:
English
Mark David Kollar, Fort Collins CO
Specialties:
Dentist
Address:
1000 Centre Ave, Fort Collins, CO 80526
Dental Anesthetic Comprising Tetracaine And A Vasoconstrictor For Intranasal Administration
US Patent:
2012003, Feb 16, 2012
Filed:
Apr 2, 2010
Appl. No.:
13/262704
Inventors:
Mark David Kollar - Fort Collins CO, US
Assignee:
ST. RENATUS, LLC - Fort Collins CO
International Classification:
A61K 31/245, A61M 11/00, A61P 23/02, A61K 31/415, A61K 9/14
US Classification:
424400, 514537, 514401, 12820014
Abstract:
The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically anesthetizing body tissues. The present invention also relates to tetracaine based dental anesthetic formulations and methods for anesthetizing the maxillary dental arch using these formulations.